Member

Biophoundry


Biophoundry specializes in advancing scalable engineered phage-based solutions for therapeutics, diagnostics, and bio-molecular engineering. It is shifting the paradigm from phage discovery to phage design. Its team leverages expertise in synthetic biology, machine learning, and data science to accelerate the development of precision antibiotics and address critical healthcare challenges such as antimicrobial resistance.

Industries

biotechnology

Nr. of Employees

small (1-50)

Biophoundry

Biophoundry is currently seeking investment

Biophoundry is seeking a seed investment in the range of 1m-5m

All Investment-seeking Members

Expertise Areas

  • Phage therapeutic development
  • Synthetic biology
  • Bio-molecular engineering
  • Diagnostics innovation
  • Show More (1)

Key Technologies

  • Phage engineering
  • Synthetic biology tools
  • Cell-free expression systems
  • Machine learning for protein design
  • Show More (1)

Key People

CEO & Co-Founder

LinkedIn

Senior Scientist

LinkedIn

Senior ML Scientist

LinkedIn

News & Updates

Appointment of Michael Stam, a Senior ML Scientist, to advance and validate phage platform development.

Relocation of laboratory operations to Biolabs Chapel Hill.

Completion of project for the development of a phage platform pipeline.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.